Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 1/20 | 0.53 |
| ▸ | EHMT2 | Q96KQ7 | 7/20 | 0.51 |
| ▸ | EHMT1 | Q9H9B1 | 7/20 | 0.51 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.44 |
| ▸ | FLT3 | P36888 | 1/20 | 0.42 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.39 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.39 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.39 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22441468 | 1.00 | NCF1 (0.53) | NCF1EHMT2EHMT1ENPP1FLT3 | |
| SCHEMBL22445589 | 1.00 | NCF1 (0.53) | NCF1EHMT2EHMT1ENPP1FLT3 | |
| SCHEMBL22441558 | 0.94 | NCF1 (0.59) | NCF1EHMT2EHMT1ENPP1FLT3 | |
| SCHEMBL22445487 | 0.94 | NCF1 (0.59) | NCF1EHMT2EHMT1ENPP1FLT3 | |
| SCHEMBL22441473 | 0.91 | EHMT2 (0.55) | NCF1EHMT2EHMT1ENPP1FLT3 | |
| SCHEMBL22445583 | 0.91 | EHMT2 (0.55) | NCF1EHMT2EHMT1ENPP1FLT3 | |
| SCHEMBL29354516 | 0.91 | EHMT2 (0.55) | NCF1EHMT2EHMT1ENPP1FLT3 | |
| SCHEMBL22445672 | 0.90 | NCF1 (0.57) | NCF1EHMT2EHMT1ENPP1FLT3 | |
| SCHEMBL22441454 | 0.85 | NCF1 (0.52) | NCF1EHMT2EHMT1ENPP1FLT3 | |
| SCHEMBL29357502 | 0.85 | NCF1 (0.52) | NCF1EHMT2EHMT1ENPP1FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113924092-B | Quinoline and quinazoline compounds and methods of use thereof | 斯汀格瑞治疗股份有限公司 | 2025-03-18 | — | — | CN | disclosed |
| EP-3941459-A1 | QUINOLINE AND QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF | Stingray Therapeutics, Inc. (US) | 2022-01-26 | — | — | EP | disclosed |